Can urinary exosomes act as treatment response markers in prostate cancer?

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Mitchell, Paul J ^a   Welton, Joanne ^a   Staffurth, John ^a   Court, Jacquelyn ^b   Mason, Malcolm D ^a   Tabi, Zsuzsanna ^a   Clayton, Aled ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; TUMOR MARKER; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EXOSOME; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; TREATMENT RESPONSE; URINALYSIS; ADULT; AGED; CHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; TREATMENT OUTCOME; TUMOR CELL LINE; URINE;

ADULT; AGED; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; EXOSOMES; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 60549099598     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-4     Document Type: Article

References (35)

1. Woodsona K O'Reillyc KJ Hansona JC Nelsonc D Walka EL Tangrea JA The Usefulness of the Detection of GSTP1 Methylation in Urine as a Biomarker in the Diagnosis of Prostate Cancer J Urol 2008, 179:508-512. 10.1016/ j.juro.2007.09.073 18076912
2. Laxman B Tomlins SA Mehra R Morris DS Wang L Helgeson BE Shah RB Rubin MA Wei JT Chinnaiyan AM Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer Neoplasia 8:885-888. 1715928 17059688 10.1593/neo.06625
3. Sokoll LJ Ellis W Lange P Noteboom J Elliott DJ Deras IL Blase A Koo S Sarno M Rittenhouse H Groskopf J Vessella R A multicenter evaluation of the PCA3 molecular urine test: Pre-analytical effects, analytical performance, and diagnostic accuracy Clin Chim Acta 2008, 389:1-6. 10.1016/j.cca.2007.11.003 18061575
4. Crocitto LE Korns D Kretzner L Shevchuk T Blair SL Wilson TG Ramin SA Kawachi MH Smith SS Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results Urology 2004, 64:821-825. 10.1016/j.urology.2004.05.007 15491741
5. Botchkina GI Kim RH Botchkina IL Kirshenbaum A Frischer Z Adler HL Noninvasive Detection of Prostate Cancer by Quantitative Analysis of Telomerase Activity Clin Cancer Res 2005, 11:3243-3249. 10.1158/ 1078-0432.CCR-04-1919 15867219
6. Fujita K Ewing CM Sokoll LJ Elliott DJ Cunningham M De Marzo AM Isaacs WB Pavlovich CP Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation Prostate 2008, 68:872-882. 2562260 18361406 10.1002/ pros.20755
7. van Dieijen-Visser MP Hendriks MW Delaere KP Gijzen AH Brombacher PJ The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer Clin Chim Acta 1988, 177:77-80. 10.1016/ 0009-8981(88)90309-9 2460272
8. Adamson AS Francis JL Witherow RO Snell ME Urinary tissue factor levels in prostatic carcinoma: A potential marker of metastatic spread? Br J Urol 1992, 71:587-592. 10.1111/j.1464-410X.1993.tb16030.x
9. Chan LW Moses MA Goley E Sproull M Muanza T Coleman CN Figg WD Albert PS Menard C Camphausen K Urinary VEGF and MMP Levels As Predictive Markers of 1-Year Progression-Free Survival in Cancer Patients Treated With Radiation Therapy: A Longitudinal Study of Protein Kinetics Throughout Tumor Progression and Therapy J Clin Oncol 2004, 22:499-506. 10.1200/ JCO.2004.07.022 14752073
10. Irani J Salomon L Soulié M Zlotta A de la Taille A Doré B Millet C Urinary/serum prostate-specific antigen ratio: Comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection Urology 2005, 65:533-537. 10.1016/j.urology.2004.10.003 15780371
11. Hoque MO Topaloglu O Begum S Henrique R Rosenbaum E Van Criekinge W Westra WH Sidransky D Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects J Clin Oncol 2005, 23:6569-6575. 10.1200/ JCO.2005.07.009 16170165
12. Vener T Derecho C Baden J Wang H Rajpurohit Y Skelton J Mehrotra J Varde S Chowdary D Stallings W Leibovich B Robin H Pelzer A Schafer G Auprich M Mannweiler S Amersdorfer P Mazumder A Development of a Multiplexed Urine Assay for Prostate Cancer Diagnosis Clin Chem 2008, 54:874-882. 10.1373/clinchem.2007.094912 18339699
13. Laxman B Morris DS Yu J Siddiqui J Cao J Mehra R Lonigro RJ Tsodikov A Wei JT Tomlins SA Chinnaiyan AM A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer Cancer Res 2008, 68:645-649. 10.1158/0008-5472.CAN-07-3224 18245462
14. Pisitkun T Shen R Knepper M Identification and proteomic profiling of exosomes in human urine Proc Natl Acad Sci USA 2004, 101:13369-13373. 10.1073/pnas.0403453101
15. Zhou H Pisitkun T Aponte A Yuen PST Hoffert JD Yasuda H Hu X Chawla L Shen R-F Knepper MA Star RA Exosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury 2006, 70:1847-1857. 2277342 17021608
16. Yu X Harris SL Levine AJ The Regulation of Exosome Secretion: A Novel Function of the p53 Protein Cancer Res 2006, 66:4795-4801. 10.1158/ 0008-5472.CAN-05-4579 16651434
17. Andre F Schartz NE Movassagh M Flament C Pautier P Morice P Pomel C Lhomme C Escudier B Le Chevalier T Tursz T Amigorena S Raposo G Angevin E Zitvogel L Malignant effusions and immunogenic tumour-derived exosomes Lancet 2002, 360:295-305. 10.1016/S0140-6736(02)09552-1 12147373
18. Wolfers J Lozier A Raposo G Regnault A Thery C Masurier C Flament C Pouzieux S Faure F Tursz T Angevin E Amigorena S Zitvogel L Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming Nat Med 2001, 7:297-303. 10.1038/85438 11231627
19. Zeelenberg IS Ostrowski M Krumeich S Bobrie A Jancic C Boissonnas A Delcayre A Le Pecq J-B Combadiere B Amigorena S Thery C Targeting Tumor Antigens to Secreted Membrane Vesicles In vivo Induces Efficient Antitumor Immune Responses Cancer Res 2008, 68:1228-1235. 10.1158/ 0008-5472.CAN-07-3163 18281500
20. Dai S Wei D Wu Z Zhou X Wei X Huang H Li G Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined with GM-CSF for Colorectal Cancer Mol Ther 2008, 16:782-790. 10.1038/mt.2008.1 18362931
21. Liu C Yu S Zinn K Wang J Zhang L Jia Y Kappes JC Barnes S Kimberly RP Grizzle WE Zhang H-G Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function J Immunol 2006, 176:1375-1385. 16424164
22. Valenti R Huber V Filipazzi P Pilla L Sovena G Villa A Corbelli A Fais S Parmiani G Rivoltini L Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-{beta}-Mediated Suppressive Activity on T Lymphocytes Cancer Res 2006, 66:9290-9298. 10.1158/0008-5472.CAN-06-1819 16982774
23. Clayton A Mitchell JP Court J Mason MD Tabi Z Human tumour-derived exosomes selectively impair lymphocyte responses to Interleukin-2 Cancer Res 2007, 67:7458-7466. 10.1158/0008-5472.CAN-06-3456 17671216
24. Clayton A Mitchell JP Court J Linnane S Mason MD Tabi Z Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression J Immunol 2008, 180:7249-7258. 18490724
25. Gesierich S Berezovskiy I Ryschich E Zoller M Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029 Cancer Res 2006, 66:7083-7094. 10.1158/0008-5472.CAN-06-0391 16849554
26. Hao S Ye Z Li F Meng Q Qureshi M Yang J Xiang J Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes Exp Oncol 2006:28.
27. Shedden K Xie XT Chandaroy P Chang YT Rosania GR Expulsion of Small Molecules in Vesicles Shed by Cancer Cells: Association with Gene Expression and Chemosensitivity Profiles Cancer Res 2003, 63:4331-4337. 12907600
28. Carsberg C Myers K Evans G Allen T Stern P Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane J Cell Sci 1995, 108:2905-2916. 7593330
29. Lamparski H Metha-Damani A Yao J Patel S Hsu D Ruegg C Le Pecq J Production and characterization of clinical grade exosomes derived from dendritic cells J Immunol Methods 2002, 270:211-226. 12379326
30. Mitchell JP Court J Mason MD Tabi Z Clayton A Increased exosome production from tumour cell cultures using the Integra CELLine Culture System J Immunol Methods 2008, 335:98-105. 10.1016/j.jim.2008.03.001 18423480
31. Clayton A Harris CL Court J Mason MD Morgan BP Antigen presenting cell exosomes are protected from complement mediated lysis by expression of CD55 and CD59 Eur J Immunol 2003, 33:552-531. 10.1002/immu.200310028
32. Clayton A Court J Navabi H Adams M Mason MD Hobot JA Newman GR Jasani B Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry J Immunol Methods 2001, 247:163-174. 10.1016/S0022-1759(00)00321-5 11150547
33. Raposo G Nijman HW Stoorvogel W Leijendekker R Harding CV Melief CJM Geuze HJ B Lymphocytes secrete Antigen-presenting Vesicles J Exp Med 1996, 183:1161-1172. 2192324 8642258 10.1084/jem.183.3.1161
34. Zhou H Yuen PS Pisitkun T Gonzales PA Yasuda H Dear JW Gross P Knepper MA RA S Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery Kidney Int 2006, 69(8):1471-1476. 2276656 16501490
35. Taylor DD Gercel-Taylor C MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol Oncol 2008, 110:1-2. 10.1016/j.ygyno.2008.04.033 18589207